BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 23, 2026
See today's BioWorld
Home
» Domestic industry groups condemn India's price cap exemption for novel drugs
To read the full story,
subscribe
or
sign in
.
Domestic industry groups condemn India's price cap exemption for novel drugs
Jan. 18, 2019
By
David Ho
HONG KONG – The Indian Ministry of Chemicals and Fertilizers has exempted foreign makers of new drugs patented under India's Patents Act 1970 (39 of 1970) from price regulation for five years.
BioWorld